Identification of potential drug targets in Salmonella enterica sv. Typhimurium using metabolic modelling and experimental validation

Microbiology (United Kingdom)

Volumn 160, Issue PART 6, 2014, Pages 1252-1266

  Hartman, Hassan B ^a   Fell, David A ^a   Rossell, Sergio ^b,f   Jensen, Peter Ruhdal ^b   Woodward, Martin J ^c   Thorndahl, Lotte ^d   Jelsbak, Lotte ^d   Olsen, John Elmerdahl ^d   Raghunathan, Anu ^e,g   Daefler, Simon ^e   Poolman, Mark G ^a  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF READING   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

^g NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; ASPARTATE AMMONIA LYASE; COENZYME A; GLUCOSE; GLUTAMATE DEHYDROGENASE; MALATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANTIBIOTIC RESISTANCE; BACTERIAL METABOLISM; BACTERIUM IDENTIFICATION; BIOMASS PRODUCTION; CITRIC ACID CYCLE; DRUG IDENTIFICATION; DRUG TARGETING; EDITORIAL; GENETIC ASSOCIATION; GENOME; GLYCOLYSIS; METABOLIC FLUX ANALYSIS; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN TARGETING; REACTION ANALYSIS; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SYSTEM ANALYSIS;

EID: 84901717015     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.076091-0     Document Type: Editorial

References (54)

1. AbuOun, M., Suthers, P. F., Jones, G. I., Carter, B. R., Saunders, M. P., Maranas, C. D., Woodward, M. J. & Anjum, M. F. (2009). Genome scale reconstruction of a Salmonella metabolic model: comparison of similarity and differences with a commensal Escherichia coli strain. J Biol Chem 284, 29480-29488.
2. Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M. & other authors (2005). A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307, 223-227.
3. Baothman, O. A. S., Rolfe, M. D. & Green, J. (2013). Characterization of Salmonella enterica serovar Typhimurium aconitase A. Microbiology 159, 1209-1216.
4. Bauchop, T. & Elsden, S. R. (1960). The growth of micro-organisms in relation to their energy supply. J Gen Microbiol 23, 457-469.
5. Becker, D., Selbach, M., Rollenhagen, C., Ballmaier, M., Meyer, T. F., Mann, M. & Bumann, D. (2006). Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 440, 303-307.
6. Bowden, S. D., Rowley, G., Hinton, J. C. D. & Thompson, A. (2009). Glucose and glycolysis are required for the successful infection of macrophages and mice by Salmonella enterica serovar Typhimurium. Infect Immun 77, 3117-3126.
7. Bowden, S. D., Ramachandran, V. K., Knudsen, G. M., Hinton, J. C. & Thompson, A. (2010). An incomplete TCA cycle increases survival of Salmonella Typhimurium during infection of resting and activated murine macrophages. PLoS ONE 5, e13871.
8. Cano, D. A., Pucciarelli, M. G., Martínez-Moya, M., Casadesús, J. & García-del Portillo, F. (2003). Selection of small-colony variants of Salmonella enterica serovar Typhimurium in nonphagocytic eucaryotic cells. Infect Immun 71, 3690-3698.
9. Chaudhuri, R. R., Peters, S. E., Pleasance, S. J., Northen, H., Willers, C., Paterson, G. K., Cone, D. B., Allen, A. G., Owen, P. J. & other authors (2009). Comprehensive identification of Salmonella enterica serovar Typhimurium genes required for infection of BALB/c mice. PLoS Pathog 5, e1000529.
10. Cohen, P. S. (2010). Live attenuated aldose-negative bacterial vaccine. US Patent US 20100003284. A1.
11. Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97, 6640-6645.
12. Edwards, J. S. & Palsson, B. O. (2000). The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities. Proc Natl Acad Sci U S A 97, 5528-5533.
13. Feist, A. M., Henry, C. S., Reed, J. L., Krummenacker, M., Joyce, A. R., Karp, P. D., Broadbelt, L. J., Hatzimanikatis, V. & Palsson, B. O. (2007). A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 3, 121.
14. Fell, D. A. & Small, J. R. (1986). Fat synthesis in adipose tissue. An examination of stoichiometric constraints. Biochem J 238, 781-786.
15. Fuhrer, T. & Sauer, U. (2009). Different biochemical mechanisms ensure network-wide balancing of reducing equivalents in microbial metabolism. J Bacteriol 191, 2112-2121.
16. García-del Portillo, F., Núñez-Hernández, C., Eisman, B. & Ramos-Vivas, J. (2008). Growth control in the Salmonella-containing vacuole. Curr Opin Microbiol 11, 46-52.
17. Gevorgyan, A., Poolman, M. G. & Fell, D. A. (2008). Detection of stoichiometric inconsistencies in biomolecular models. Bioinformatics 24, 2245-2251.
18. Görke, B. & Stülke, J. (2008). Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat Rev Microbiol 6, 613-624.
19. Gruer, M. J., Bradbury, A. J. & Guest, J. R. (1997). Construction and properties of aconitase mutants of Escherichia coli. Microbiology 143, 1837-1846.
20. Holzhütter, H.-G. (2004). The principle of flux minimization and its application to estimate stationary fluxes in metabolic networks. Eur J Biochem 271, 2905-2922.
21. Holzhütter, H.-G. (2006). The generalized flux-minimization method and its application to metabolic networks affected by enzyme deficiencies. Biosystems 83, 98-107.
22. Huerta-Cepas, J., Dopazo, J. & Gabaldón, T. (2010). ETE: a Python environment for tree exploration. BMC Bioinformatics 11, 24.
23. Hughes, J. A. (2006). In vivo hydrolysis of S-adenosyl-L-methionine in Escherichia coli increases export of 5-methylthioribose. Can J Microbiol 52, 599-602.
24. Jelsbak, L., Thomsen, L. E., Wallrodt, I., Jensen, P. R. & Olsen, J. E. (2012). Polyamines are required for virulence in Salmonella enterica serovar Typhimurium. PLoS ONE 7, e36149.
25. Karp, P. D., Paley, S. & Romero, P. (2002). The Pathway Tools software. Bioinformatics 18 (Suppl. 1), S225-S232.
26. Klamt, S. & Gilles, E. D. (2004). Minimal cut sets in biochemical reaction networks. Bioinformatics 20, 226-234.
27. Maloney, P. C. (1987). Coupling to an energized membrane: role of ion-motive gradients in the tranduction of metabolic energy. In Escherichia Coli and Salmonella Typhimurium. Cellular and Molecular Biology, vol. 1, pp. 222-243. Edited by F. C. Neidhardt. Washington, DC: American Society for Microbiology.
28. McClelland, M., Sanderson, K. E., Spieth, J., Clifton, S. W., Latreille, P., Courtney, L., Porwollik, S., Ali, J., Dante, M. & other authors (2001). Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413, 852-856.
29. Mercado-Lubo, R., Gauger, E. J., Leatham, M. P., Conway, T. & Cohen, P. S. (2008). A Salmonella enterica serovar Typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice. Infect Immun 76, 1128-1134.
30. Miller, K. A., Phillips, R. S., Mrázek, J. & Hoover, T. R. (2013). Salmonella utilizes D-glucosaminate via a mannose family phosphotransferase system permease and associated enzymes. J Bacteriol 195, 4057-4066.
31. Murphy, D. J. & Brown, J. R. (2007). Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect Dis 7, 84.
32. Norrby, S. R., Nord, C. E., Finch, R. & European Society of Clinical Microbiology and Infectious Diseases (2005). Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5, 115-119.
33. Paterson, D. L. (2006). Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med 119 (Suppl. 1), S20-S28, discussion S62-S70.
34. Pfeiffer, T., Sánchez-Valdenebro, I., Nuño, J. C., Montero, F. & Schuster, S. (1999). METATOOL: for studying metabolic networks. Bioinformatics 15, 251-257.
35. Poolman, M. G. (2006). ScrumPy: metabolic modelling with Python. Syst Biol (Stevenage) 153 (5), 375-378.
36. Poolman, M. G., Sebu, C., Pidcock, M. K. & Fell, D. A. (2007). Modular decomposition of metabolic systems via null-space analysis. J Theor Biol 249, 691-705.
37. Poolman, M. G., Miguet, L., Sweetlove, L. J. & Fell, D. A. (2009). A genome-scale metabolic model of Arabidopsis and some of its properties. Plant Physiol 151, 1570-1581.
38. Poolman, M. G., Kundu, S., Shaw, R. & Fell, D. A. (2013). Responses to light intensity in a genome-scale model of rice metabolism. Plant Physiol 162, 1060-1072.
39. Prost, L. R., Sanowar, S. & Miller, S. I. (2007). Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages. Immunol Rev 219, 55-65.
40. Raghunathan, A., Reed, J., Shin, S., Palsson, B. & Daefler, S. (2009). Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction. BMC Syst Biol 3, 38.
41. Rao, S. P. S., Alonso, S., Rand, L., Dick, T. & Pethe, K. (2008). The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 105, 11945-11950.
42. Richardson, E. J., Limaye, B., Inamdar, H., Datta, A., Manjari, K. S., Pullinger, G. D., Thomson, N. R., Joshi, R. R., Watson, M. & Stevens, M. P. (2011). Genome sequences of Salmonella enterica serovar Typhimurium, Choleraesuis, Dublin, andGallinarumstrains of well-defined virulence in food-producing animals. J Bacteriol 193, 3162-3163.
43. Steeb, B., Claudi, B., Burton, N. A., Tienz, P., Schmidt, A., Farhan, H., Mazé, A. & Bumann, D. (2013). Parallel exploitation of diverse host nutrients enhances Salmonella virulence. PLoS Pathog 9, e1003301.
44. Tchawa Yimga, M., Leatham, M. P., Allen, J. H., Laux, D. C., Conway, T. & Cohen, P. S. (2006). Role of gluconeogenesis and the tricarboxylic acid cycle in the virulence of Salmonella enterica serovar Typhimurium in BALB/c mice. Infect Immun 74, 1130-1140.
45. Thiele, I., Hyduke, D. R., Steeb, B., Fankam, G., Allen, D. K., Bazzani, S., Charusanti, P., Chen, F. C., Fleming, R. M. & other authors (2011). A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2. BMC Syst Biol 5, 8.
46. Tierrez, A. & García-del Portillo, F. (2005). New concepts in Salmonella virulence: the importance of reducing the intracellular growth rate in the host. Cell Microbiol 7, 901-909.
47. Varma, A. & Palsson, B. O. (1993a). Metabolic capabilities of Escherichia coli: I. Synthesis of biosynthetic precursors and cofactors. J Theor Biol 165, 477-502.
48. Varma, A. & Palsson, B. O. (1993b). Metabolic capabilities of Escherichia coli: II. Optimal growth patterns. J Theor Biol 165, 503-522.
49. Wallis, T. S., Paulin, S. M., Plested, J. S., Watson, P. R. & Jones, P. W. (1995). The Salmonella dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis in cattle. Infect Immun 63, 2755-2761.
50. Watson, M. R. (1986). A discrete model of bacterial metabolism. Comput Appl Biosci 2, 23-27.
51. Wayne, L. G. & Sohaskey, C. D. (2001). Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 55, 139-163.
52. Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T. & Rubin, H. (2005). Inhibitors of type II NADH: menaquinone oxidoreductase represent a class of antitubercular drugs. Proc Natl Acad Sci U S A 102, 4548-4553.
53. Yu, B. J., Sung, B. H., Lee, J. Y., Son, S. H., Kim, M. S. & Kim, S. C. (2006). sucAB and sucCD are mutually essential genes in Escherichia coli. FEMS Microbiol Lett 254, 245-250.
54. Zomorrodi, A. R., Suthers, P. F., Ranganathan, S. & Maranas, C. D. (2012). Mathematical optimization applications in metabolic networks. Metab Eng 14, 672-686.